Jami Rubin, a pharmaceuticals analyst with Morgan Stanley, believes New Jersey Superior Court Judge Carol Higbee has tried, through her actions and rulings, to dissuade Merck from pursuing a long and drawn out legal fight.
FORBES: A Hopeful Sign For Merck